Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA)
CUSIP: 74365U107
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 54,102,569
- Total 13F shares
- 6,311,961
- Share change
- -798,882
- Total reported value
- $43,679,692
- Price per share
- $6.92
- Number of holders
- 36
- Value change
- -$8,598,514
- Number of buys
- 17
- Number of sells
- 19
Quarterly Holders Quick Answers
What is CUSIP 74365U107?
CUSIP 74365U107 identifies TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74365U107:
Top shareholders of TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. |
13F
|
Company |
4.7%
|
2,558,472
|
$24,920,000 | — | 30 Jun 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.3%
|
693,542
|
$6,755,000 | — | 30 Jun 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.1%
|
584,804
|
$5,696,000 | — | 30 Jun 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.83%
|
450,000
|
$4,383,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.81%
|
437,108
|
$4,258,000 | — | 30 Jun 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.78%
|
421,641
|
$4,107,000 | — | 30 Jun 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.65%
|
350,010
|
$3,409,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.63%
|
342,021
|
$3,331,000 | — | 30 Jun 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
0.39%
|
209,227
|
$2,038,000 | — | 30 Jun 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.37%
|
199,671
|
$1,945,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.24%
|
132,257
|
$1,288,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.24%
|
129,380
|
$1,260,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
82,985
|
$808,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.11%
|
58,318
|
$568,000 | — | 30 Jun 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
56,883
|
$554,000 | — | 30 Jun 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.1%
|
55,405
|
$540,000 | — | 30 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
51,427
|
$501,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
48,855
|
$475,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.07%
|
40,125
|
$391,000 | — | 30 Jun 2021 | |
| David M. Knott |
13F
|
Individual |
0.07%
|
36,164
|
$352,000 | — | 30 Jun 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.05%
|
24,455
|
$238,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
22,279
|
$217,000 | — | 30 Jun 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
20,609
|
$201,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
17,907
|
$174,000 | — | 30 Jun 2021 | |
| Ergoteles LLC |
13F
|
Company |
0.03%
|
17,700
|
$172,000 | — | 30 Jun 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.03%
|
17,469
|
$170,000 | — | 30 Jun 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
13,678
|
$133,000 | — | 30 Jun 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.02%
|
12,151
|
$118,000 | — | 30 Jun 2021 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
11,700
|
$114,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
10,359
|
$101,000 | — | 30 Jun 2021 | |
| Martin Sebastian Olivo |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
14,344
|
$27,397 | — | 10 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,548
|
$15,000 | — | 30 Jun 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
—
class O/S missing
|
954
|
$9,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
932
|
$9,000 | — | 30 Jun 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
559
|
$6,000 | — | 30 Jun 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
581
|
$5,000 | — | 30 Jun 2021 | |
| Retirement Group, LLC |
13F
|
Company |
0%
|
500
|
$5,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
177
|
$2,000 | — | 30 Jun 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
99
|
$1,000 | — | 30 Jun 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
55
|
$1,000 | — | 30 Jun 2021 |
Institutional Holders of Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) as of Q3 2021
As of 30 Sep 2021,
Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,311,961 shares.
The largest 10 holders included
Opaleye Management Inc., Ikarian Capital, LLC, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, CITADEL ADVISORS LLC, BOXER CAPITAL, LLC, BAKER BROS. ADVISORS LP, TWO SIGMA ADVISERS, LP, and GOLDMAN SACHS GROUP INC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
38
Q3 2021 holders
36
Holder diff
-2
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.